- Home
- APRE vs AMBO Comparison
APRE vs AMBO Comparison
Compare APRE & AMBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APRE
- AMBO
- Stock Information
- Founded
- APRE 2006
- AMBO 2000
- Country
- APRE United States
- AMBO United States
- Employees
- APRE N/A
- AMBO 163
- Industry
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- AMBO Other Consumer Services
- Sector
- APRE Health Care
- AMBO Real Estate
- Exchange
- APRE Nasdaq
- AMBO Nasdaq
- Market Cap
- APRE 9.7M
- AMBO 8.8M
- IPO Year
- APRE 2019
- AMBO 2010
- Fundamental
- Price
- APRE $1.65
- AMBO $3.29
- Analyst Decision
- APRE Strong Buy
- AMBO
- Analyst Count
- APRE 2
- AMBO 0
- Target Price
- APRE $15.50
- AMBO N/A
- AVG Volume (30 Days)
- APRE 17.1K
- AMBO 25.3K
- Earning Date
- APRE 05-20-2025
- AMBO 12-30-2024
- Dividend Yield
- APRE N/A
- AMBO N/A
- EPS Growth
- APRE N/A
- AMBO N/A
- EPS
- APRE N/A
- AMBO 0.11
- Revenue
- APRE $1,502,581.00
- AMBO $9,392,000.00
- Revenue This Year
- APRE N/A
- AMBO N/A
- Revenue Next Year
- APRE N/A
- AMBO N/A
- P/E Ratio
- APRE N/A
- AMBO $30.65
- Revenue Growth
- APRE 157.63
- AMBO 2.50
- 52 Week Low
- APRE $1.41
- AMBO $1.00
- 52 Week High
- APRE $5.90
- AMBO $5.55
- Technical
- Relative Strength Index (RSI)
- APRE 41.84
- AMBO 66.62
- Support Level
- APRE $1.67
- AMBO $2.82
- Resistance Level
- APRE $1.99
- AMBO $3.50
- Average True Range (ATR)
- APRE 0.14
- AMBO 0.35
- MACD
- APRE 0.04
- AMBO 0.06
- Stochastic Oscillator
- APRE 41.55
- AMBO 80.37
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
About AMBO Ambow Education Holding Ltd.
Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.